Stock Rating Downgrade
The Value Trend Rating for Astrazeneca PLC (NASDAQ: AZN) weakened during the last several trading days from B to C reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our next report.
Recent Price Action
Astrazeneca PLC (NASDAQ: AZN) stock closed at $67.62 on 11/29/24 after a modest gain of 0.6%. However, exceptionally low trading volume at 47% of normal accompanied the advance. The stock has risen 7.0% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
Astrazeneca has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Astrazeneca has a neutral Appreciation Score of 54 and a neutral Power Rating of 48, triggering the Neutral Value Trend Rating.
Be the first to comment